Harmony Biosciences Holdings (HRMY) EBT Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 9,460.35% |
| 10 | Harmony Biosciences Holdings | 1.83 Bn | 1.19 Bn | 170.88 Mn | -30.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.59% |
| Dec 31, 2025 | -27.42% |
| Sep 30, 2025 | 8.56% |
| Jun 30, 2025 | 128.81% |
| Mar 31, 2025 | 10.41% |
| Dec 31, 2024 | 41.49% |
| Sep 30, 2024 | 19.95% |
| Jun 30, 2024 | -50.80% |
| Mar 31, 2024 | 37.07% |
| Dec 31, 2023 | -10.01% |
| Sep 30, 2023 | 550.58% |
| Jun 30, 2023 | 50.85% |
| Mar 31, 2023 | 61.56% |
| Dec 31, 2022 | 80.20% |
| Sep 30, 2022 | 175.72% |
| Jun 30, 2022 | 81.68% |
| Mar 31, 2022 | 216.61% |
| Dec 31, 2021 | 11,866.83% |
| Sep 30, 2021 | -651.18% |
| Jun 30, 2021 | 59,688.89% |
| Mar 31, 2021 | 119.12% |
| Dec 31, 2020 | 99.43% |
| Sep 30, 2020 | 105.98% |